| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 28, 2025 | Apr 1, 2025 | Perspective Therapeutics, Inc. | CEO | Buy | 95.0 | +26,676 | 43.73% | ✗ | $59.7K |
| Dec 4, 2024 | Dec 4, 2024 | Perspective Therapeutics, Inc. | CEO | Buy | 91.3 | +8,000 | 16.93% | ✗ | $30.1K |
| Nov 25, 2024 | Nov 26, 2024 | Perspective Therapeutics, Inc. | CEO | Buy | 95.0 | +26,500 | 12.77% | ✗ | $100.5K |
| Jun 13, 2024 | Jun 13, 2024 | Perspective Therapeutics, Inc. | CEO | Buy | 95.0 | +100,000 | 92.96% | ✗ | $117.4K |
| Dec 28, 2018 | Jan 2, 2019 | Entero Therapeutics, Inc. | CEO | Buy | 91.3 | +38,583 | 11.35% | ✗ | $50K |